デフォルト表紙
市場調査レポート
商品コード
1053667

持続血糖モニタリング機器の市場シェア、規模、動向、産業分析レポート(2022年~2029年):最終用途別、コンポーネントタイプ別、地域別、セグメント別予測

Continuous Glucose Monitoring Device Market Share, Size, Trends, Industry Analysis Report By End-Use (Homecare Diagnostics, Hospitals); By Component Type; By Region; Segment Forecast, 2022 - 2029

出版日: | 発行: Polaris Market Research | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
持続血糖モニタリング機器の市場シェア、規模、動向、産業分析レポート(2022年~2029年):最終用途別、コンポーネントタイプ別、地域別、セグメント別予測
出版日: 2022年01月01日
発行: Polaris Market Research
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の持続血糖モニタリング機器の市場規模は2029年までに147億8,000万米ドルになると予想されています。

当レポートでは世界の持続血糖モニタリング機器市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、最終用途別、コンポーネントタイプ別、地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • レポートの説明
    • 調査の目的
    • 市場範囲
    • 仮定
  • 利害関係者

第2章 エグゼクティブサマリー

  • 市場のハイライト

第3章 調査手法

  • 概要
    • データマイニング
  • データソース
    • 一次資料
    • 二次資料

第4章 持続血糖モニタリング機器市場の洞察

  • 業界のスナップショット
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
    • 供給企業の交渉力(中)
    • 新規参入者の脅威(低)
    • 買い手の交渉力(中)
    • 代替の脅威(中)
    • 既存企業間の競争(高)
  • PESTLE分析
  • バリューチェーン分析
  • 業界の動向
  • COVID-19の影響分析

第5章 世界の持続血糖モニタリング機器市場:コンポーネントタイプ別

  • 主な調査結果
  • イントロダクション
    • コンポーネントタイプ別:2017年~2029年
  • 送信機と受信機
    • 送信機と受信機、地域別:2017年~2029年
  • センサー
    • センサー、地域別:2017年~2029年
  • インスリンポンプ
    • インスリンポンプ、地域別:2017年~2029年

第6章 世界の持続血糖モニタリング機器市場:最終用途別

  • 主な調査結果
  • イントロダクション
    • 最終用途別:2017年~2029年
  • 病院
    • 病院、地域別:2017年~2029年
  • 在宅医療診断
    • 在宅医療診断、地域別:2017年~2029年
  • その他
    • その他、地域別:2017年~2029年

第7章 世界の持続血糖モニタリング機器市場:地域別

  • 主な調査結果
  • イントロダクション
    • 地域別:2017年~2029年
  • 北米
    • 最終用途別:2017年~2029年
    • コンポーネントタイプ別:2017年~2029年
    • 米国
    • カナダ
  • 欧州
    • 最終用途別:2017年~2029年
    • コンポーネントタイプ別:2017年~2029年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ベルギー
    • オーストリア
    • ロシア
  • アジア太平洋地域
    • 最終用途別:2017年~2029年
    • コンポーネントタイプ別:2017年~2029年
    • 中国
    • インド
    • マレーシア
    • 日本
    • シンガポール
    • フィリピン
    • インドネシア
    • タイ
    • 韓国
  • 中東およびアフリカ
    • 最終用途別:2017年~2029年
    • コンポーネントタイプ別:2017年~2029年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • 最終用途別:2017年~2029年
    • コンポーネントタイプ別:2017年~2029年
    • メキシコ
    • ブラジル
    • アルゼンチン

第8章 競合情勢

  • 拡張および買収分析
    • 拡張
    • 買収
  • パートナーシップ/コラボレーション/契約/展示会

第9章 企業プロファイル

  • A. Menarini Diagnostics
  • Echo Therapeutics, Inc.
  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Glycens
  • GlySens Incorporated
  • Insulet Corporation
  • Johnson & Johnson
  • LifeScan
  • Medtronic plc.
  • Medtrum Technologies Inc.
  • Microchip Technology Inc.
  • Nemaura Medical, Inc.
  • Novo Nordisk
  • NXP Semiconductors
  • Qualcomm
  • Roche Diagnostics
  • Senseonics Holdings, Inc.
  • STMicroelectronics
  • Tandem Diabetes Care
図表

List of Tables

  • Table 1 Global Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 2 Global Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 3 Continuous Glucose Monitoring Device Market Assessment, By Geography, 2017 - 2029 (USD Billion)
  • Table 4 North America: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 5 North America: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 6 U.S.: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 7 U.S.: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 8 Canada: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 9 Canada: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 10 Europe: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 11 Europe: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 12 Germany: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 13 Germany: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 14 UK: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 15 UK: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 16 Italy: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 17 Italy: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 18 France: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 19 France: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 20 Netherlands: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 21 Netherlands: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 22 Belgium: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 23 Belgium: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 24 Spain: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 25 Spain: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 26 Austria: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 27 Austria: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 28 Russia: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 29 Russia: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 30 Asia Pacific: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 31 Asia Pacific: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 32 India: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 33 India: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 34 Japan: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 35 Japan: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 36 China: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 37 China: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 38 Indonesia: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 39 Indonesia: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 40 Malaysia: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 41 Malaysia: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 42 South Korea: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 43 South Korea: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 44 Singapore: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 45 Singapore: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 46 Thailand: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 47 Thailand: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 48 Phillippines: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 49 Phillippines: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 50 Latin America: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 51 Latin America: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 52 Mexico: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 53 Mexico: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 54 Argentina: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 55 Argentina: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 56 Brazil: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 57 Brazil: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 58 Middle East & Africa: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 59 Middle East & Africa: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 60 Israel: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 61 Israel: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 62 Saudi Arabia: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 63 Saudi Arabia: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 64 UAE: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 65 UAE: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • Table 66 South Africa: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • Table 67 South Africa: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)

List of Figures

Figure 1 Global Continuous Glucose Monitoring Device Market, 2017 - 2029 (USD Billion)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by End-Use

Figure 7 Global Continuous Glucose Monitoring Device Market, by End-Use, 2021 & 2029 (USD Billion)

Figure 8 Market by Component Type

Figure 9 Global Continuous Glucose Monitoring Device Market, by Component Type, 2021 & 2029 (USD Billion)

Figure 10 Continuous Glucose Monitoring Device Market Assessment, By Geography, 2017 - 2029 (USD Billion)

Figure 11 Strategic Analysis - Continuous Glucose Monitoring Device Market

目次
Product Code: PM1608

The global continuous glucose monitoring device market size is expected to reach USD 14.78 billion by 2029 according to a new study by Polaris Market Research. The report "Continuous Glucose Monitoring Device Market Share, Size, Trends, Industry Analysis Report By End-Use (Homecare Diagnostics, Hospitals); By Component Type; By Region; Segment Forecast, 2022 - 2029" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing diabetes rates across the globe have led to increased cardiovascular diseases such as heart attack, strokes, kidney damage, and others, which is expected to boost the demand for these products over the forecast period. For instance, in 2019, as per the International Diabetes Federation (IDF), about 462.9 Billion people were affected by diabetes globally.

Technology advancement along with innovative features like ease of use, alarm, mealtime alerts, among others, is expected to benefit the industry growth. Furthermore, the outbreak of the COVID-19 pandemic has increased health-related concerns and awareness among individuals, which in turn is expected to increase the demand for the product over the forecast period.

North America is expected to hold the major share over the forecast period due to the presence of major industry players along with increasing technological advancement in these products. However, Asia Pacific is expected to grow at a significant rate due to increasing diabetic patients in countries such as China and India.

Some of the players operating in the global industry include Echo Therapeutics, Inc., A. Menarini Diagnostics, Abbott Laboratories, Dexcom, Inc., Bayer AG, Glycens, GlySens Incorporated, Insulet Corporation, F. Hoffmann-La Roche Ltd., STMicroelectronics, GE Healthcare, Johnson & Johnson, Medtronic plc, LifeScan, Medtrum Technologies, Inc., Micron Technology Inc., Microchip Technology Inc., Nemaura Medical, Inc., NXP Semiconductors, Novo Nordisk, Qualcomm, Senseonics Holdings, Inc., Roche Diagnostics, and Tandem Diabetes Care.

Polaris Market Research has segmented the continuous glucose monitoring device market report on the basis of component type, end-use, and region:

Continuous Glucose Monitoring Device, Component Type Outlook (Revenue - USD Billion, 2017 - 2029)

Transmitters & Receivers

Sensors

Insulin Pumps

Continuous Glucose Monitoring Device, End-Use Outlook (Revenue - USD Billion, 2017 - 2029)

Hospitals

Homecare Diagnostics

Others

Continuous Glucose Monitoring Device, Regional Outlook (Revenue - USD Billion, 2017 - 2029)

North America

U.S.

Canada

Europe

Germany

UK

Italy

France

Spain

Austria

Netherlands

Belgium

Russia

Asia Pacific

China

Japan

India

Indonesia

Malaysia

South Korea

Singapore

Thailand

Philippines

Latin America

Brazil

Argentina

Mexico

Middle East & Africa

Israel

Saudi Arabia

South Africa

UAE

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Continuous Glucose Monitoring Device Market Insights

  • 4.1. Continuous Glucose Monitoring Device Market - Industry Snapshot
  • 4.2. Continuous Glucose Monitoring Device Market Dynamics
    • 4.2.1. Drivers and Opportunities
    • 4.2.2. Restraints and Challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Continuous Glucose Monitoring Device Industry trends
  • 4.7. COVID-19 Impact Analysis

5. Global Continuous Glucose Monitoring Device Market, by Component Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Continuous Glucose Monitoring Device, by Component Type, 2017 - 2029 (USD Billion)
  • 5.3. Transmitters & Receivers
    • 5.3.1. Global Continuous Glucose Monitoring Device Market, by Transmitters & Receivers, by Region, 2017 - 2029 (USD Billion)
  • 5.4. Sensors
    • 5.4.1. Global Continuous Glucose Monitoring Device Market, by Sensors, by Region, 2017 - 2029 (USD Billion)
  • 5.5. Insulin Pumps
    • 5.5.1. Global Continuous Glucose Monitoring Device Market, by Insulin Pumps, by Region, 2017 - 2029 (USD Billion)

6. Global Continuous Glucose Monitoring Device Market, by End-Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Continuous Glucose Monitoring Device Market, by Hospitals, by Region, 2017 - 2029 (USD Billion)
  • 6.4. Homecare Diagnostics
    • 6.4.1. Global Continuous Glucose Monitoring Device Market, by Homecare Diagnostics, by Region, 2017 - 2029 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Continuous Glucose Monitoring Device Market, by Others, by Region, 2017 - 2029 (USD Billion)

7. Global Continuous Glucose Monitoring Device Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Continuous Glucose Monitoring Device Market Assessment, By Geography, 2017 - 2029 (USD Billion)
  • 7.3. Continuous Glucose Monitoring Device Market - North America
    • 7.3.1. North America: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
    • 7.3.2. North America: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.3.3. Continuous Glucose Monitoring Device Market - U.S.
      • 7.3.3.1. U.S.: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.3.3.2. U.S.: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.3.4. Continuous Glucose Monitoring Device Market - Canada
      • 7.3.4.1. Canada: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.3.4.2. Canada: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • 7.4. Continuous Glucose Monitoring Device Market - Europe
    • 7.4.1. Europe: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
    • 7.4.2. Europe: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.3. Continuous Glucose Monitoring Device Market - UK
      • 7.4.3.1. UK: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.3.2. UK: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.4. Continuous Glucose Monitoring Device Market - France
      • 7.4.4.1. France: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.4.2. France: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.5. Continuous Glucose Monitoring Device Market - Germany
      • 7.4.5.1. Germany: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.5.2. Germany: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.6. Continuous Glucose Monitoring Device Market - Italy
      • 7.4.6.1. Italy: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.6.2. Italy: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.7. Continuous Glucose Monitoring Device Market - Spain
      • 7.4.7.1. Spain: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.7.2. Spain: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.8. Continuous Glucose Monitoring Device Market - Netherlands
      • 7.4.8.1. Netherlands: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.8.2. Netherlands: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.9. Continuous Glucose Monitoring Device Market - Belgium
      • 7.4.9.1. Belgium: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.9.2. Belgium: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.10. Continuous Glucose Monitoring Device Market - Austria
      • 7.4.10.1. Austria: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.10.2. Austria: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.4.11. Continuous Glucose Monitoring Device Market - Russia
      • 7.4.11.1. Russia: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.4.11.2. Russia: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • 7.5. Continuous Glucose Monitoring Device Market - Asia Pacific
    • 7.5.1. Asia Pacific: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
    • 7.5.2. Asia Pacific: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.3. Continuous Glucose Monitoring Device Market - China
      • 7.5.3.1. China: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.3.2. China: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.4. Continuous Glucose Monitoring Device Market - India
      • 7.5.4.1. India: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.4.2. India: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.5. Continuous Glucose Monitoring Device Market - Malaysia
      • 7.5.5.1. Malaysia: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.5.2. Malaysia: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.6. Continuous Glucose Monitoring Device Market - Japan
      • 7.5.6.1. Japan: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.6.2. Japan: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.7. Continuous Glucose Monitoring Device Market - Singapore
      • 7.5.7.1. Singapore: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.7.2. Singapore: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.8. Continuous Glucose Monitoring Device Market - Philippines
      • 7.5.8.1. Philippines: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.8.2. Philippines: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.9. Continuous Glucose Monitoring Device Market - Indonesia
      • 7.5.9.1. Indonesia: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.9.2. Indonesia: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.10. Continuous Glucose Monitoring Device Market - Thailand
      • 7.5.10.1. Thailand: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.10.2. Thailand: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.5.11. Continuous Glucose Monitoring Device Market - South Korea
      • 7.5.11.1. South Korea: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.5.11.2. South Korea: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • 7.6. Continuous Glucose Monitoring Device Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
    • 7.6.2. Middle East & Africa: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.6.3. Continuous Glucose Monitoring Device Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.6.4. Continuous Glucose Monitoring Device Market - UAE
      • 7.6.4.1. UAE: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.6.4.2. UAE: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.6.5. Continuous Glucose Monitoring Device Market - Israel
      • 7.6.5.1. Israel: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.6.5.2. Israel: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.6.6. Continuous Glucose Monitoring Device Market - South Africa
      • 7.6.6.1. South Africa: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.6.6.2. South Africa: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
  • 7.7. Continuous Glucose Monitoring Device Market - Latin America
    • 7.7.1. Latin America: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
    • 7.7.2. Latin America: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.7.3. Continuous Glucose Monitoring Device Market - Mexico
      • 7.7.3.1. Mexico: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.7.3.2. Mexico: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.7.4. Continuous Glucose Monitoring Device Market - Brazil
      • 7.7.4.1. Brazil: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.7.4.2. Brazil: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)
    • 7.7.5. Continuous Glucose Monitoring Device Market - Argentina
      • 7.7.5.1. Argentina: Continuous Glucose Monitoring Device Market, by End-Use, 2017 - 2029 (USD Billion)
      • 7.7.5.2. Argentina: Continuous Glucose Monitoring Device Market, by Component Type, 2017 - 2029 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. A. Menarini Diagnostics
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Echo Therapeutics, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Abbott Laboratories
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bayer AG
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Dexcom, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. F. Hoffmann-La Roche Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. GE Healthcare
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Glycens
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. GlySens Incorporated
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Insulet Corporation
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Johnson & Johnson
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. LifeScan
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Medtronic plc.
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Medtrum Technologies Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Microchip Technology Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Nemaura Medical, Inc.
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. Novo Nordisk
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development
  • 9.18. NXP Semiconductors
    • 9.18.1. Company Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Development
  • 9.19. Qualcomm
    • 9.19.1. Company Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Recent Development
  • 9.20. Roche Diagnostics
    • 9.20.1. Company Overview
    • 9.20.2. Financial Performance
    • 9.20.3. Product Benchmarking
    • 9.20.4. Recent Development
  • 9.21. Senseonics Holdings, Inc.
    • 9.21.1. Company Overview
    • 9.21.2. Financial Performance
    • 9.21.3. Product Benchmarking
    • 9.21.4. Recent Development
  • 9.22. STMicroelectronics
    • 9.22.1. Company Overview
    • 9.22.2. Financial Performance
    • 9.22.3. Product Benchmarking
    • 9.22.4. Recent Development
  • 9.23. Tandem Diabetes Care
    • 9.23.1. Company Overview
    • 9.23.2. Financial Performance
    • 9.23.3. Product Benchmarking
    • 9.23.4. Recent Development